Macrocytic anemia is a form of anemia characterized by abnormally large red blood cells (RBCs) with an increased mean corpuscular volume (MCV > 100 fL). In this condition, the production or maturation of RBCs in the bone marrow is disrupted, leading to fewer cells in circulation and impaired oxygen delivery to tissues. Macrocytosis often reflects a defect in DNA synthesis (megaloblastic anemia) or other secondary processes (non‐megaloblastic anemia). Common signs include fatigue, pallor, and in certain types, neurological changes due to vitamin B₁₂ deficiency. Recognizing macrocytic anemia early is vital, as targeted treatment can reverse cell‐size abnormalities and prevent complications.
Macrocytic anemia is a type of anemia characterized by abnormally large red blood cells (mean corpuscular volume > 100 fL) accompanied by a reduced total red cell count and hemoglobin concentration. In simple terms, the cells grow too big because they can’t divide at the right time, which usually happens when DNA synthesis is impaired—most often due to deficiencies of vitamin B₁₂ or folate (“megaloblastic” anemia) or, less commonly, from liver disease, alcohol use, hypothyroidism, or certain medications (“non‐megaloblastic” anemia) NCBIWikipedia.
Types of Macrocytic Anemia
Macrocytic anemia divides into two main categories based on the underlying mechanism:
1. Megaloblastic Anemia.
In megaloblastic anemia, impaired DNA synthesis—most often due to vitamin B₁₂ or folate deficiency—halts proper nuclear maturation. As a result, bone‑marrow precursors (megaloblasts) swell and develop large, immature nuclei alongside cytoplasmic maturation that is relatively advanced. Common causes include pernicious anemia, malabsorption syndromes, and certain medications that interfere with folate metabolism.
2. Non‑megaloblastic Macrocytic Anemia.
Non‑megaloblastic macrocytosis occurs without classic megaloblast morphology and intact DNA synthesis. Instead, other factors cause enlarged RBCs, such as chronic alcohol use, liver disease, hypothyroidism, reticulocytosis (young RBCs are larger), or marrow stress due to hemolysis or marrow failure. The absence of hypersegmented neutrophils and the presence of normal nuclear maturation in bone‑marrow cells help distinguish non‑megaloblastic forms.
Causes of Macrocytic Anemia
Vitamin B₁₂ Deficiency. Without enough B₁₂, DNA synthesis slows, causing megaloblastic changes. Common in pernicious anemia, where intrinsic factor loss impairs B₁₂ absorption.
Folate Deficiency. Folate is crucial for DNA building blocks; poor diet, malabsorption, or increased demand (e.g., pregnancy) can deplete folate and trigger megaloblastosis.
Alcoholism. Chronic alcohol intake directly suppresses marrow function and alters folate metabolism, leading to macrocytosis even without true deficiency.
Liver Disease. Liver dysfunction alters lipid composition of RBC membranes, making red cells larger. Fatty liver and cirrhosis commonly show macrocytosis.
Hypothyroidism. Low thyroid hormone slows erythropoiesis and prolongs RBC lifespan, allowing cells to become larger.
Myelodysplastic Syndrome. Bone‐marrow disorders with abnormal stem cells produce dysplastic, oversized RBC precursors, often leading to macrocytic anemia.
Chemotherapy (e.g., Methotrexate). Antimetabolite drugs impair DNA synthesis in rapidly dividing cells, including erythroid precursors, causing macrocytosis.
Zidovudine Therapy. In HIV treatment, zidovudine inhibits DNA polymerase in marrow cells, frequently leading to macrocytosis.
Hydroxyurea Treatment. Used for myeloproliferative disorders, hydroxyurea reduces DNA synthesis in marrow, resulting in larger RBCs.
Phenytoin and Other Antiepileptics. Drugs like phenytoin and valproate interfere with folate metabolism, occasionally causing macrocytosis.
Reticulocytosis. When hemolysis or bleeding triggers high reticulocyte release, the larger young cells elevate average MCV.
Pregnancy. Increased plasma volume and folate demand may transiently enlarge RBCs, especially if nutritional intake is inadequate.
Gastric Surgery (Gastrectomy). Removal of stomach tissue can impair intrinsic‐factor production and B₁₂ absorption, leading to deficiency.
Celiac Disease. Intestinal villous atrophy reduces absorption of B₁₂ and folate, causing megaloblastic changes.
Trimethoprim–Sulfonamide Use. Folate‐antagonist antibiotics can induce folate deficiency and macrocytosis.
Orotic Aciduria. A rare inherited disorder of pyrimidine synthesis, leading to megaloblastic anemia and orotic acid buildup.
Copper Deficiency. Though uncommon, low copper can impair iron metabolism and cause macrocytosis with anemia.
Aplastic Anemia. General marrow failure reduces cell numbers; surviving erythroblasts may be dysplastic and large.
Paroxysmal Nocturnal Hemoglobinuria. Complement‐mediated hemolysis drives reticulocytosis and may be accompanied by macrocytosis.
Azathioprine Use. As an antimetabolite, azathioprine disrupts DNA replication in marrow cells, resulting in larger red cells.
Symptoms of Macrocytic Anemia
Fatigue. Reduced oxygen delivery makes everyday activities exhausting.
Weakness. Muscle strength declines when tissues receive less oxygen.
Pallor. Pale skin and mucous membranes reflect fewer circulating red cells.
Shortness of Breath. The heart and lungs work harder to compensate for anemia.
Palpitations. Patients may feel a racing heartbeat as the heart pumps more vigorously.
Glossitis. Swollen, inflamed tongue—common in B₁₂ and folate deficiencies.
Cheilosis. Cracks or sores at the corners of the mouth, also linked to nutritional deficiencies.
Diarrhea. Folate deficiency sometimes leads to gastrointestinal symptoms.
Numbness and Tingling. Peripheral neuropathy from B₁₂ deficiency causes “pins and needles.”
Ataxia. Impaired coordination and balance result from spinal‐cord involvement in B₁₂ deficiency.
Memory Loss. Cognitive slowing and forgetfulness can accompany long‐standing B₁₂ deficiency.
Irritability. Mood changes, including irritability and depression, may emerge with anemia.
Depression. Low oxygenation and neurotransmitter disruptions contribute to depressive symptoms.
Jaundice. Mild yellowing of skin and eyes from increased breakdown of abnormal red cells.
Splenomegaly. Enlarged spleen from heightened clearance of defective or oversized red cells.
Further Diagnostic Tests
Physical Examination Tests
Skin and Mucous Membrane Inspection. Examining pallor and jaundice clues to anemia severity.
Tongue Examination. Checking for smooth, red glossitis typical of megaloblastic anemia.
Neurological Assessment. Testing vibration and position sense to detect B₁₂‐related neuropathy.
Cardiopulmonary Exam. Listening for tachycardia or flow murmurs from high‐output anemia.
Manual (Bedside) Tests
Schilling Test. Historical assay to measure B₁₂ absorption with and without intrinsic factor.
Direct Coombs Test. A manual agglutination assay to rule out autoimmune hemolysis contributing to reticulocytosis.
Osmotic Fragility Test. Evaluates red cell stability—may be abnormal if cell membranes are altered.
Bone Marrow Smear Examination. Direct visual appraisal of marrow aspirates for megaloblasts or dysplasia.
Laboratory and Pathological Tests
Complete Blood Count with Indices. Confirms macrocytosis (MCV > 100 fL) and overall cell counts.
Reticulocyte Count. Measures marrow response; low in production defects, high in hemolysis.
Peripheral Blood Smear. Identifies hypersegmented neutrophils, anisopoikilocytosis, or tear‐drop cells.
Serum Vitamin B₁₂ Level. Direct measure of B₁₂ stores; low in deficiency states.
Serum Folate Level. Assesses folate status; low in nutritional deficiency or malabsorption.
Serum Methylmalonic Acid. Elevated specifically in B₁₂ deficiency, more sensitive than serum B₁₂.
Plasma Homocysteine. Raised in both B₁₂ and folate deficiencies, indicating impaired methylation.
Thyroid Function Tests. TSH and T₄ levels to detect hypothyroidism as a non‐megaloblastic cause.
Liver Function Tests. AST, ALT, ALP, bilirubin to evaluate hepatic disease leading to macrocytosis.
Viral Serologies. HIV and hepatitis panels when drug therapies or chronic infection are suspected culprits.
Electrodiagnostic Tests
Nerve Conduction Studies. Quantify peripheral neuropathy often seen in prolonged B₁₂ deficiency.
Somatosensory Evoked Potentials. Assess integrity of sensory pathways in subacute combined degeneration.
Non‑Pharmacological Treatments
Below are supportive therapies and lifestyle interventions that can help correct or mitigate macrocytic anemia by addressing underlying causes, improving nutrient status, or enhancing overall well‑being. Each is described with its purpose and mechanism.
Alcohol Abstinence
Description: Complete avoidance of alcohol intake.
Purpose: To reverse alcohol‑induced folate deficiency and direct marrow toxicity.
Mechanism: Alcohol damages red cell precursors and depletes folate stores; abstinence allows the bone marrow and folate levels to recover, normalizing cell size within weeks to months NCBI.Gluten‑Free Diet (in Celiac Disease)
Description: Lifelong exclusion of wheat, barley, and rye.
Purpose: To heal intestinal villi, restoring absorption of vitamin B₁₂, folate, and other nutrients.
Mechanism: Eliminates gluten‑triggered mucosal damage, allowing villous regrowth over 6–18 months and correction of nutrient malabsorption GIG® Gluten Intolerance Group®.Nutritional Counseling
Description: Dietitian‑led planning to increase B₁₂‑ and folate‑rich foods (e.g., leafy greens, legumes, fortified cereals, animal proteins).
Purpose: To boost endogenous intake of critical vitamins.
Mechanism: Optimizes diet patterns for gradual restoration of vitamin levels, supporting normal DNA synthesis in erythroid precursors Cleveland Clinic.Patient Education & Self‑Monitoring
Description: Teaching symptom recognition (fatigue, pallor, neuropathy) and when to seek care.
Purpose: Early detection of recurrence or complications.
Mechanism: Empowers patients to report changes promptly, enabling timely laboratory checks and interventions Cleveland Clinic.Smoking Cessation
Description: Quitting all tobacco products.
Purpose: To normalize red cell indices altered by smoking‑induced erythrocyte death and compensatory polycythemia.
Mechanism: Smoking triggers oxidative damage and premature red cell death; cessation allows hematologic parameters to return to normal over years PubMed.Avoidance of Offending Medications
Description: Discontinuing or substituting drugs known to cause macrocytosis (e.g., methotrexate, zidovudine).
Purpose: To remove iatrogenic DNA‑synthesis inhibitors.
Mechanism: Eliminates the drug‑induced block in folate or cobalamin metabolism, permitting normal erythropoiesis NCBI.Moderate, Graded Exercise
Description: Low‑impact activities (walking, yoga, cycling) tailored to tolerance.
Purpose: To improve oxygen delivery and reduce fatigue.
Mechanism: Enhances cardiovascular efficiency and tissue oxygenation, helping patients cope with lower hemoglobin levels Cleveland Clinic.Adequate Hydration
Description: Drinking 1.5–2 L of fluids daily (water, broths).
Purpose: To maintain plasma volume and optimize red cell rheology.
Mechanism: Prevents hemoconcentration, improving microcirculation and oxygen delivery Cancer.org.Stress Management Techniques
Description: Practices such as deep breathing, meditation, or mindfulness.
Purpose: To support overall health and adherence to therapy.
Mechanism: Reduces cortisol‑mediated nutritional malabsorption and promotes restful behaviors SAGE Journals.Good Sleep Hygiene
Description: Regular sleep schedule, darkened room, limiting screens.
Purpose: To support bone marrow recovery and overall healing.
Mechanism: Adequate sleep promotes hormonal balance (e.g., growth hormone) that supports erythropoiesis SAGE Journals.Cognitive Behavioral Therapy (CBT)
Description: Structured psychotherapy focusing on coping skills.
Purpose: To manage emotional distress from chronic illness.
Mechanism: Teaches strategies to reframe negative thoughts, improving mood, adherence, and energy levels Wikipedia.Peer‑Support Groups
Description: Facilitated patient meetings (in‑person or online).
Purpose: To share experiences, reduce isolation, and encourage self‑care.
Mechanism: Social support enhances motivation for lifestyle changes and treatment compliance Wikipedia.Occupational Therapy
Description: Techniques to conserve energy during daily tasks.
Purpose: To maintain independence despite fatigue.
Mechanism: Teaches prioritization, pacing, and adaptive equipment use, reducing overall physical strain.Regular Follow‑Up & Monitoring
Description: Scheduled CBC checks every 6–12 months once stable.
Purpose: To detect relapse or complications early.
Mechanism: Tracks red cell indices and nutrient levels, guiding timely adjustments NCBI.Avoidance of High Altitudes
Description: Minimizing time spent above 2,500 m without acclimatization.
Purpose: To prevent exacerbation of hypoxia and compensatory macrocytosis.
Mechanism: Limits hypoxia‑induced erythropoietin surge that can worsen symptoms UC Davis Health.Sunlight Exposure
Description: 10–15 minutes of midday sun several times weekly.
Purpose: To boost vitamin D status and overall immune health.
Mechanism: Supports bone marrow environment and reduces infection risk.Balanced Weight‑Bearing Activities
Description: Tai chi or gentle strength training.
Purpose: To maintain muscle mass and bone health.
Mechanism: Promotes overall vitality, aiding recovery from anemia.Occupational & Environmental Avoidance Counseling
Description: Reducing exposure to toxins (e.g., benzene, nitrous oxide).
Purpose: To prevent acquired marrow suppression.
Mechanism: Limits direct chemical injury to hematopoietic precursors.**Nutrition‑Focused **Cooking Classes
Description: Hands‑on learning of folate/B₁₂‑rich recipes.
Purpose: To translate dietary guidance into practical meals.
Mechanism: Enhances patient engagement and dietary adherence.Mind‑Body Practices (e.g., Yoga, Tai Chi)
Description: Gentle movement combined with breath work.
Purpose: To improve circulation and reduce stress.
Mechanism: Supports oxygen delivery and mental well‑being.
Evidence‑Based Drugs
Below are ten cornerstone pharmacologic agents used in macrocytic anemia, with dosage, class, timing, and key side effects.
Hydroxocobalamin (Vitamin B₁₂)
Class: Water‑soluble vitamin
Dosage: 1,000 µg IM weekly × 4 weeks, then monthly
Administration: Intramuscular injection
Side Effects: Injection‑site pain, mild diarrhea, rare hypersensitivity NCBI.
Cyanocobalamin (Vitamin B₁₂)
Class: Water‑soluble vitamin
Dosage: 1,000 µg IM or deep SC daily × 1 week, then weekly × 1 month, then monthly
Administration: Injection or high‑dose oral in some cases
Side Effects: Similar to hydroxocobalamin; risk of fluid overload in severe deficiency.
Folic Acid (Vitamin B₉)
Class: Water‑soluble vitamin
Dosage: 1–5 mg PO daily
Administration: Oral, with or without food
Side Effects: Rare gastric upset at high doses The ObG Project.
Methionine
Class: Amino acid supplement
Dosage: 500 mg PO three times daily
Administration: Oral
Side Effects: Nausea, dizziness, hyperhomocysteinemia risk.
Erythropoietin Alfa
Class: Erythropoiesis‑stimulating agent
Dosage: 50–150 units/kg SC three times weekly
Administration: Subcutaneous injection
Side Effects: Hypertension, thromboembolism, pure red cell aplasia risk.
Darbepoetin Alfa
Class: Erythropoiesis‑stimulating agent
Dosage: 0.45 µg/kg SC weekly
Administration: Subcutaneous injection
Side Effects: Similar to erythropoietin alfa; less frequent dosing.
Hydroxyurea (for MDS‑related Macrocytosis)
Class: Antimetabolite
Dosage: 15–20 mg/kg PO daily
Administration: Oral
Side Effects: Myelosuppression, mucositis, rash.
Thymidine (investigational)
Class: Nucleoside analog
Dosage: Under study
Administration: IV infusion
Side Effects: Experimental.
Vitamin B₁₂ Nasal Gel
Class: Water‑soluble vitamin
Dosage: 500 µg in one nostril weekly
Administration: Intranasal
Side Effects: Nasal irritation.
Leucovorin (Folinic Acid)
Class: Folate analog
Dosage: 5–15 mg IV/IM daily for 5 days, then oral 1 mg daily
Administration: IV, IM, or oral
Side Effects: Bronchospasm, rash.
Dietary Molecular Supplements
These targeted supplements support cellular metabolism and DNA synthesis.
Methylcobalamin (500 µg PO daily) – active form of B₁₂; directly used in DNA synthesis and myelin repair.
5‑Methyltetrahydrofolate (5‑MTHF) (400–1,000 µg PO daily) – bioactive folate; bypasses MTHFR polymorphisms, enhances DNA methylation.
Pyridoxal‑5‑Phosphate (Vitamin B₆) (25 mg PO daily) – cofactor in homocysteine metabolism; supports red cell maturation.
Riboflavin (Vitamin B₂) (10 mg PO daily) – assists folate activation; supports mitochondrial function.
Niacin (Vitamin B₃) (20 mg PO daily) – necessary for NAD⁺ regeneration; fosters energy metabolism in marrow.
Vitamin D₃ (2,000 IU PO daily) – modulates immune function; supports marrow microenvironment.
Zinc (15 mg PO daily) – cofactor for DNA polymerases; enhances immune health.
Iron Bisglycinate (30 mg elemental Fe daily) – supports enzyme cofactors in DNA synthesis; safe in macrocytic contexts.
L‑Carnitine (1,000 mg PO daily) – improves mitochondrial fatty‑acid oxidation; supports energy in erythropoiesis.
N‑Acetylcysteine (NAC) (600 mg PO twice daily) – antioxidant; protects marrow cells from oxidative damage.
Regenerative & Stem‑Cell‑Directed Agents
(Used in refractory or marrow‑failure settings; under specialist supervision.)
Thrombopoietin Receptor Agonists (e.g., Eltrombopag)
Dosage: 50 mg PO daily
Function: Stimulates hematopoietic stem cell proliferation.
Mechanism: Activates MPL receptor on progenitors.
Romiplostim
Dosage: 1–10 µg/kg SC weekly
Function: Similar to eltrombopag; mainly for thrombocytopenia but marrow‑stimulating.
Decitabine (Low‑Dose)
Dosage: 5 mg/m² IV daily × 5 days
Function: Hypomethylating agent for MDS; can improve macrocytosis.
Mechanism: Reactivates silenced genes in hematopoiesis.
Lenalidomide
Dosage: 5–10 mg PO daily
Function: Immunomodulator for del(5q) MDS; improves red cell production.
Allogeneic Hematopoietic Stem Cell Transplant
Dosage: Conditioning + graft
Function: Curative in selected marrow‑failure syndromes.
Mechanism: Replaces defective hematopoietic system.
Autologous Mesenchymal Stem Cell Infusion (Experimental)
Dosage: Under investigation
Function: Supports marrow stroma regeneration.
Surgeries & Procedures
In select settings where anatomical correction or grafting is needed.
Bone Marrow Transplantation
Procedure: Allogeneic stem cell infusion after conditioning.
Benefits: Potential cure of refractory macrocytosis due to marrow disorders.
Splenectomy
Procedure: Laparoscopic removal of spleen.
Benefits: Reduces hemolysis in secondary causes.
Gastric Bypass Revision
Procedure: Surgical correction of malabsorptive bariatric surgery.
Benefits: Restores nutrient absorption (B₁₂, folate).
Colectomy (in IBD)
Procedure: Segmental colon resection.
Benefits: Controls inflammation and malabsorption.
Nissen Fundoplication
Procedure: Anti‑reflux surgery.
Benefits: Improves folate/B₁₂ absorption in severe GERD.
Pancreatic Enzyme Replacement (Surgical Tube Placement)
Procedure: Jejunal feeding access for enzyme delivery.
Benefits: Enhances nutrient breakdown/absorption.
Liver Transplant
Procedure: Orthotopic liver graft in end‑stage disease.
Benefits: Corrects macrocytosis from severe cirrhosis.
Parathyroidectomy
Procedure: Removal of hyperfunctioning parathyroid tissue.
Benefits: Resolves secondary macrocytosis in hyperparathyroidism.
Thyroidectomy
Procedure: Excision of thyroid in autoimmune disease.
Benefits: Normalizes thyroid function, improving anemia.
MDS‑Directed Cytoreductive Surgery
Procedure: Debulking in localized chloroma.
Benefits: Reduces malignant clone burden.
Prevention Strategies
Routine Dietary Screening for B₁₂/folate intake.
Annual CBC Monitoring in at‑risk populations (elderly, alcohol users).
Perioperative Nutrient Supplementation before bariatric or GI surgery.
Vaccination Against Viral Hepatitis to prevent liver disease.
Periodic Medication Review to avoid DNA‑synthesis inhibitors.
Celiac Serologic Screening in chronic anemia.
Alcohol‑Use Counseling in primary care.
Thyroid Function Testing when anemia is unexplained.
Prenatal Folic Acid Fortification (0.4 mg daily) for all women of childbearing age.
Public Health Fortification of grains with folate (mandated cereal enrichment) NCBINCBI.
When to See a Doctor
Seek medical attention if you experience any of the following, as these may signal worsening anemia or complications:
Persistent fatigue or pallor interfering with daily life
New or progressive numbness, tingling, or balance problems
Unexplained bruising or bleeding
Rapid heart rate, chest pain, or shortness of breath at rest
Dark or tarry stools (suggesting GI bleeding)
Jaundice or abdominal swelling (suggesting liver disease)
Unintended weight loss or night sweats
Non‑resolving GI symptoms (e.g., diarrhea, bloating)
Recent initiation of high‑risk medications (e.g., methotrexate)
Family history of marrow disorders
Foods to Eat & Avoid
Eat:
Lean meats (beef, poultry)—heme B₁₂ source
Fish (salmon, tuna)—vitamin B₁₂ & D
Leafy greens (spinach, kale)—folate
Legumes (lentils, beans)—folate & iron
Fortified cereals—folate & B₁₂
Dairy (milk, yogurt)—B₁₂
Eggs—folate & B₁₂
Nuts/seeds—vitamin E & zinc
Citrus fruits—vitamin C enhances folate/iron absorption
Whole grains—folate
Avoid:
Alcohol—impairs absorption & marrow toxicity
High‑dose aspirin/NSAIDs—GI blood loss
Tobacco—oxidative red cell damage
Excess tea/coffee—tannins inhibit nutrient absorption
Popcorn/hull foods—can irritate GI lining
Processed meats—high sodium, low nutrients
Sugary beverages—empty calories
Unfortified cereals—lack folate/B₁₂
Raw eggs—biotin depletion
High‑altitude exposure—exacerbates hypoxia
Frequently Asked Questions
What causes macrocytic anemia?
Deficiencies of vitamin B₁₂ or folate, liver disease, alcohol use, medications interfering with DNA synthesis, hypothyroidism, or bone marrow disorders NCBI.How is it diagnosed?
With a complete blood count (MCV > 100 fL), peripheral smear (macrocytes, hypersegmented neutrophils), and vitamin assays Wikipedia.Can it be cured?
Yes—by treating the underlying cause (e.g., replacing deficient vitamins, modifying diet, or adjusting medications).How fast do B₁₂ injections work?
Hematologic response often begins in 1–2 weeks; neurologic recovery may take months.Is oral B₁₂ effective?
High‑dose oral (1,000–2,000 µg daily) can work in mild deficiency if absorption is intact.Can pregnant women develop this?
Yes—due to increased folate demands; prenatal vitamins are essential.What foods are best for prevention?
Leafy greens, legumes, fortified grains, lean meats, eggs, and dairy.Is macrocytic anemia hereditary?
Rare genetic marrow disorders (e.g., congenital dyserythropoietic anemia) can be inherited.Can alcohol cause permanent damage?
Chronic abuse may lead to irreversible neurological deficits despite anemia correction.When is a bone marrow biopsy needed?
If no nutritional cause is found or if marrow pathology (e.g., MDS) is suspected.Are supplements safe long‑term?
Yes—water‑soluble vitamins are generally safe; monitor for rare side effects.Can folate mask B₁₂ deficiency?
High‑dose folate may correct anemia but not prevent neurologic damage from B₁₂ deficiency.Do proton‑pump inhibitors cause this?
Long‑term PPI use can impair B₁₂ absorption in susceptible individuals.Is sun exposure helpful?
Indirectly—vitamin D from sunlight supports immune and marrow health.How often should I have follow‑up labs?
Every 6–12 months when stable; sooner if symptoms recur.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: July 25, 2025.
